Literature DB >> 27624740

Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.

Lara Yoon1, Grace Clarke Hillyer1,2, Ling Chen3, Jim C Hu4,5, Alfred I Neugut1,2,3,5, Dawn L Hershman1,2,3,5, Jason D Wright2,3,5.   

Abstract

Venous thromboembolic disease is a major cause of morbidity in cancer patients. The Perspective database was used to identify patients with solid tumors and a diagnosis of VTE from 2006 to 2012. We examined use of IVC filters, thrombolysis, and thrombectomy. Among 32,545 patients, 23.1% received an IVC filter, 1.9% thrombolytic therapy, and 0.4% underwent thrombectomy. Use of IVC filters decreased between 2006 and 2012 (23.4% to 21.2%, p = 0.012). Older patients, uninsured patients, Hispanics, and those with more comorbidities were more likely to undergo filter placement while patients at rural hospitals were less likely to receive an IVC filter (p < 0.05 for all).

Entities:  

Keywords:  Venous thromboembolism; inferior vena cava filter; thrombectomy; thrombolysis

Mesh:

Year:  2016        PMID: 27624740      PMCID: PMC5047731          DOI: 10.1080/07357907.2016.1221078

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  27 in total

1.  Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference.

Authors:  John A Kaufman; Thomas B Kinney; Michael B Streiff; Ronald F Sing; Mary C Proctor; Daniel Becker; Mark Cipolle; Anthony J Comerota; Steven F Millward; Frederick B Rogers; David Sacks; Anthony C Venbrux
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism.

Authors:  Drew M Caplin; Boris Nikolic; Sanjeeva P Kalva; Suvranu Ganguli; Wael E A Saad; Darryl A Zuckerman
Journal:  J Vasc Interv Radiol       Date:  2011-09-03       Impact factor: 3.464

4.  The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients.

Authors:  Michael B Streiff
Journal:  Thromb Res       Date:  2010-04       Impact factor: 3.944

Review 5.  Cancer-associated thrombosis.

Authors:  Gregory C Connolly; Charles W Francis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 6.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

Review 7.  International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  D Farge; P Debourdeau; M Beckers; C Baglin; R M Bauersachs; B Brenner; D Brilhante; A Falanga; G T Gerotzafias; N Haim; A K Kakkar; A A Khorana; R Lecumberri; M Mandala; M Marty; M Monreal; S A Mousa; S Noble; I Pabinger; P Prandoni; M H Prins; M H Qari; M B Streiff; K Syrigos; H Bounameaux; H R Büller
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  High variation between hospitals in vena cava filter use for venous thromboembolism.

Authors:  Richard H White; Estella Marie Geraghty; Ann Brunson; Susan Murin; Ted Wun; Fred Spencer; Patrick S Romano
Journal:  JAMA Intern Med       Date:  2013-04-08       Impact factor: 21.873

10.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.